Connection

Miguel Abboud to Combined Modality Therapy

Back to Details
This is a "connection" page, showing publications Miguel Abboud has written about Combined Modality Therapy.
Miguel Abboud
Connection Strength
0.069
Combined Modality Therapy
  1. Establishment of a formal program for retinoblastoma: Feasibility of clinical coordination across borders and impact on outcome. Pediatr Blood Cancer. 2019 11; 66(11):e27959.
    View in: PubMed
    Score: 0.034
  2. Priapism, an emerging complication in ?-thalassemia intermedia patients. Hemoglobin. 2014; 38(5):351-4.
    View in: PubMed
    Score: 0.023
  3. Survival with combined modality therapy after intracerebral recurrence of pleuropulmonary blastoma. Med Pediatr Oncol. 1998 Jan; 30(1):63-6.
    View in: PubMed
    Score: 0.008
  4. Effects of IL-1 on hematopoietic progenitors after myelosuppressive chemoradiotherapy. Biotherapy. 1989; 1(4):293-300.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.